These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3752683)

  • 21. Pharmacokinetics and bioavailability of metformin in horses.
    Hustace JL; Firshman AM; Mata JE
    Am J Vet Res; 2009 May; 70(5):665-8. PubMed ID: 19405907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intravenous administration of dimethyl sulfoxide on cardiopulmonary and clinicopathologic variables in awake or halothane-anesthetized horses.
    Lin HC; Johnson CR; Duran SH; Waldridge BM
    J Am Vet Med Assoc; 2004 Aug; 225(4):560-6. PubMed ID: 15344364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and detection of toltrazuril sulfone and its pharmacokinetics in horses following administration in dimethylsulfoxide.
    Dirikolu L; Karpiesiuk W; Lehner AF; Hughes C; Granstrom DE; Tobin T
    J Vet Pharmacol Ther; 2009 Aug; 32(4):368-78. PubMed ID: 19614842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin pharmacokinetics, bioavailability, efficacy, and dosage regimens in the horse.
    Button C; Gross DR; Johnston JT; Yakatan GJ
    Am J Vet Res; 1980 Sep; 41(9):1388-95. PubMed ID: 7447132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological treatment of thin-film transistor liquid crystal display (TFT-LCD) wastewater.
    Lei CN; Whang LM; Lin HL
    Water Sci Technol; 2008; 58(5):1001-6. PubMed ID: 18824797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of ketoprofen in healthy foals less than twenty-four hours old.
    Wilcke JR; Crisman MV; Scarratt WK; Sams RA
    Am J Vet Res; 1998 Mar; 59(3):290-2. PubMed ID: 9522947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dimethyl sulfoxide on sulindac disposition in rats.
    Swanson BN; Mojaverian P; Boppana VK; Dudash MR
    Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin pharmacokinetics in the horse.
    Thijssen HH; van den Bogaard AE; Wetzel JM; Maes JH; Muller AP
    Am J Vet Res; 1983 Jul; 44(7):1192-6. PubMed ID: 6881659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and bioavailability of cephalothin in horse mares.
    Ruoff WW; Sams RA
    Am J Vet Res; 1985 Oct; 46(10):2085-90. PubMed ID: 4062011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ticarcillin in the horse after intravenous and intramuscular administration.
    Sweeney CR; Soma LR; Beech J; Reef V; Simmons R
    Am J Vet Res; 1984 May; 45(5):1000-2. PubMed ID: 6732002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theophylline and dyphylline pharmacokinetics in the horse.
    Ayres JW; Pearson EG; Riebold TW; Chang SF
    Am J Vet Res; 1985 Dec; 46(12):2500-6. PubMed ID: 4083583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ibuprofen after intravenous and oral administration and assessment of safety of administration to healthy foals.
    Breuhaus BA; DeGraves FJ; Honore EK; Papich MG
    Am J Vet Res; 1999 Sep; 60(9):1066-73. PubMed ID: 10490073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horses.
    Greene EW; Woods WE; Tobin T
    Am J Vet Res; 1983 Jan; 44(1):57-63. PubMed ID: 6824226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.
    Rademaker-Lakhai JM; van den Bongard D; Pluim D; Beijnen JH; Schellens JH
    Clin Cancer Res; 2004 Jun; 10(11):3717-27. PubMed ID: 15173078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of a single, orally administered dose of digoxin in horses.
    Pedersoli WM; Ravis WR; Belmonte AA; McCullers RM
    Am J Vet Res; 1981 Aug; 42(8):1412-4. PubMed ID: 7294477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of thymidine administered as large doses to rats and mice.
    Hill DL; Noker PE; Duncan GF; El Dareer SM
    Cancer Treat Rep; 1981; 65(5-6):495-9. PubMed ID: 7237470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.